Windtree Therapeutics, Inc. (WINT) Financials

$0.31

south_east
-$0.01 (-1.79%)
Day's range
$0.3
Day's range
$0.33

WINT Income statement / Annual

Last year (2023), Windtree Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Windtree Therapeutics, Inc.'s net income was -$20.29 M. See Windtree Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $198,000.00 $1.79 M $1.49 M $2.04 M $987,000.00 $2.84 M
Cost of Revenue $82,000.00 $1.06 M $869,000.00 $638,000.00 $12,687.00 $10.56 M $17.38 M $255,000.00 $929,000.00 $2.67 M
Gross Profit -$82,000.00 -$1.06 M -$869,000.00 -$638,000.00 $185,313.00 -$8.77 M -$15.89 M $1.79 M $58,000.00 $164,000.00
Gross Profit Ratio 0 0 0 0 0.94 -4.91 -10.7 0.88 0.06 0.06
Research and Development Expenses $8.26 M $11.10 M $17.79 M $15.37 M $12.69 M $10.56 M $17.38 M $31.71 M $28.89 M $26.69 M
General & Administrative Expenses $8,698.00 $10.79 M $14.47 M $14.94 M $12.40 M $7.42 M $6.66 M $7.17 M $0.00 $0.00
Selling & Marketing Expenses $9.19 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.20 M $0.00 $0.00
Selling, General & Administrative Expenses $9.20 M $10.79 M $14.47 M $14.94 M $12.40 M $7.42 M $6.66 M $8.37 M $11.00 M $16.73 M
Other Expenses $0.00 $702,000.00 -$320,000.00 -$2.25 M -$446,000.00 $401,000.00 $129,000.00 $0.00 $0.00 $0.00
Operating Expenses $17.46 M $21.89 M $32.26 M $30.32 M $25.09 M $17.98 M $24.03 M $40.08 M $39.89 M $43.42 M
Cost And Expenses $17.54 M $21.89 M $32.26 M $30.32 M $25.09 M $17.98 M $24.03 M $40.08 M $40.82 M $46.09 M
Interest Income $325,000.00 $109,000.00 $91,000.00 $122,000.00 $153,000.00 $15,000.00 $12,000.00 $18,000.00 $237,000.00 $6,000.00
Interest Expense $50,000.00 $53,000.00 $114,000.00 $125,000.00 $495,000.00 $1.41 M $1.86 M $2.52 M $4.67 M $4.60 M
Depreciation & Amortization $82,000.00 $1.06 M $869,000.00 $638,000.00 $1.11 M $159,000.00 $192,000.00 $255,000.00 $712,000.00 $818,000.00
EBITDA -$20.16 M -$39.46 M -$76.64 M -$31.80 M -$25.87 M -$18.97 M -$16.39 M -$36.72 M -$49.88 M -$38.64 M
EBITDA Ratio 0 0 0 0 -116.66 -8.74 -14.96 -19.14 -39.4 -14.98
Operating Income Ratio 0 0 0 0 -125.72 -9.06 -15.18 -18.63 -40.36 -15.26
Total Other Income/Expenses Net -$2.75 M -$19.09 M -$45.36 M -$2.25 M -$2.58 M -$4.34 M $4.10 M -$1.45 M -$15.34 M -$800,000.00
Income Before Tax -$20.29 M -$40.58 M -$77.62 M -$32.57 M -$27.48 M -$20.53 M -$18.45 M -$39.49 M -$55.17 M -$44.06 M
Income Before Tax Ratio 0 0 0 0 -138.76 -11.48 -12.42 -19.34 -55.9 -15.54
Income Tax Expense $0.00 -$1.37 M -$9.99 M -$2.29 M $2.39 M -$2.93 M $1.99 M $1.20 M $4.67 M -$18,000.00
Net Income -$20.29 M -$39.21 M -$67.64 M -$30.28 M -$29.86 M -$20.53 M -$18.45 M -$39.49 M -$55.17 M -$44.06 M
Net Income Ratio 0 0 0 0 -150.82 -11.48 -12.42 -19.34 -55.9 -15.54
EPS -92.23 -980.2 -2254.53 -1514 -2986.2 -685.51 -2691.67 -14230.63 -23759.69 -21746.3
EPS Diluted -92.23 -980.2 -2254.53 -1514 -2986.2 -685.51 -2691.67 -14230.63 -23759.69 -21512.7
Weighted Average Shares Out $220,000.00 $40,000.00 $30,000.00 $20,000.00 $10,000.00 $29,953.00 $6,853.00 $2,775.00 $2,322.00 $2,026.00
Weighted Average Shares Out Diluted $220,000.00 $40,000.00 $30,000.00 $20,000.00 $10,000.00 $29,953.00 $6,853.00 $2,775.00 $2,322.00 $2,048.00
Link